Ick Chan Kwon - Search Results

Year	Number of Results
2002	6
2003	8
2004	11
2005	8
2006	7
2007	11
2008	22
2009	17
2010	35
2011	32
2012	34
2013	33
2014	32
2015	22
2016	27
2017	26
2018	10
2019	14
2020	13
2021	6
2022	5
2023	4
2024	4

1

Exosome-Guided Phenotypic Switch of M1 to M2 Macrophages for Cutaneous Wound Healing.

Kim H, Wang SY, Kwak G, Yang Y, Kwon IC, Kim SH. Kim H, et al. Among authors: kwon ic. Adv Sci (Weinh). 2019 Aug 27;6(20):1900513. doi: 10.1002/advs.201900513. eCollection 2019 Oct 16. Adv Sci (Weinh). 2019. PMID: 31637157 Free PMC article.

2

Inorganic Nanoparticles for Image-Guided Therapy.

Yoon HY, Jeon S, You DG, Park JH, Kwon IC, Koo H, Kim K. Yoon HY, et al. Among authors: kwon ic. Bioconjug Chem. 2017 Jan 18;28(1):124-134. doi: 10.1021/acs.bioconjchem.6b00512. Epub 2016 Nov 21. Bioconjug Chem. 2017. PMID: 27788580 Review.

3

Exosome-guided direct reprogramming of tumor-associated macrophages from protumorigenic to antitumorigenic to fight cancer.

Kim H, Park HJ, Chang HW, Back JH, Lee SJ, Park YE, Kim EH, Hong Y, Kwak G, Kwon IC, Lee JE, Lee YS, Kim SY, Yang Y, Kim SH. Kim H, et al. Among authors: kwon ic. Bioact Mater. 2022 Aug 5;25:527-540. doi: 10.1016/j.bioactmat.2022.07.021. eCollection 2023 Jul. Bioact Mater. 2022. PMID: 37056267 Free PMC article.

4

Polysaccharide-based Nanoparticles for Gene Delivery.

Huh MS, Lee EJ, Koo H, Yhee JY, Oh KS, Son S, Lee S, Kim SH, Kwon IC, Kim K. Huh MS, et al. Among authors: kwon ic. Top Curr Chem (Cham). 2017 Apr;375(2):31. doi: 10.1007/s41061-017-0114-y. Epub 2017 Mar 1. Top Curr Chem (Cham). 2017. PMID: 28251564 Review.

5

Engineering nanoparticle strategies for effective cancer immunotherapy.

Yoon HY, Selvan ST, Yang Y, Kim MJ, Yi DK, Kwon IC, Kim K. Yoon HY, et al. Among authors: kwon ic. Biomaterials. 2018 Sep;178:597-607. doi: 10.1016/j.biomaterials.2018.03.036. Epub 2018 Mar 21. Biomaterials. 2018. PMID: 29576282 Review.

6

Tumor-Targeting Glycol Chitosan Nanoparticles for Cancer Heterogeneity.

Ryu JH, Yoon HY, Sun IC, Kwon IC, Kim K. Ryu JH, et al. Among authors: kwon ic. Adv Mater. 2020 Dec;32(51):e2002197. doi: 10.1002/adma.202002197. Epub 2020 Oct 13. Adv Mater. 2020. PMID: 33051905 Review.

7

Molecularly engineered siRNA conjugates for tumor-targeted RNAi therapy.

Lee JW, Choi J, Choi Y, Kim K, Yang Y, Kim SH, Yoon HY, Kwon IC. Lee JW, et al. Among authors: kwon ic. J Control Release. 2022 Nov;351:713-726. doi: 10.1016/j.jconrel.2022.09.040. Epub 2022 Oct 7. J Control Release. 2022. PMID: 36152808 Free article. Review.

8

Extracellular Vesicles as Potential Therapeutics for Inflammatory Diseases.

Hwang HS, Kim H, Han G, Lee JW, Kim K, Kwon IC, Yang Y, Kim SH. Hwang HS, et al. Among authors: kwon ic. Int J Mol Sci. 2021 May 22;22(11):5487. doi: 10.3390/ijms22115487. Int J Mol Sci. 2021. PMID: 34067503 Free PMC article. Review.

9

PDL1-binding peptide/anti-miRNA21 conjugate as a therapeutic modality for PD-L1^high tumors and TAMs.

Kim EH, Lee J, Kwak G, Jang H, Kim H, Cho H, Jang Y, Choi J, Chi SG, Kim K, Kwon IC, Yang Y, Kim SH. Kim EH, et al. Among authors: kwon ic. J Control Release. 2022 May;345:62-74. doi: 10.1016/j.jconrel.2022.02.031. Epub 2022 Mar 6. J Control Release. 2022. PMID: 35263615

10

Theranostic nanoparticles for future personalized medicine.

Ryu JH, Lee S, Son S, Kim SH, Leary JF, Choi K, Kwon IC. Ryu JH, et al. Among authors: kwon ic. J Control Release. 2014 Sep 28;190:477-84. doi: 10.1016/j.jconrel.2014.04.027. Epub 2014 Apr 26. J Control Release. 2014. PMID: 24780269 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

341 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

341 results

Results by year